 | • レポートコード：QFJ1-5502 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、狂犬病モノクローナル抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カテゴリーII暴露、カテゴリーIII暴露）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・狂犬病モノクローナル抗体の市場動向 ・企業の競争状況、市場シェア ・狂犬病モノクローナル抗体の種類別市場規模と予測2016-2027（カテゴリーII暴露、カテゴリーIII暴露） ・狂犬病モノクローナル抗体の用途別市場規模と予測2016-2027（大人用、子供用） ・狂犬病モノクローナル抗体の北米市場規模2016-2027（アメリカ、カナダ） ・狂犬病モノクローナル抗体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・狂犬病モノクローナル抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・狂犬病モノクローナル抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・狂犬病モノクローナル抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Serum Institute of India、NCPC、Crucell、Zydus、Synermore Biologics） ・結論 |
Anti-rabies virus monoclonal antibody is a passive immune preparation, which has the same or better neutralizing effect as rabies immunoglobulin. The development of anti-rabies virus monoclonal antibodies to replace traditional human immunoglobulin and immune antiserum products is an important direction of international research in this field in recent years. WHO also strongly recommends the use of monoclonal antibody combination preparations to replace rabies immunoglobulin to solve rabies The problem of insufficient supply of immunoglobulins.
In 2021, the global Rabies Monoclonal Antibody market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Rabies Monoclonal Antibody status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Rabies Monoclonal Antibody development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Rabies Monoclonal Antibody Scope and Market Size
Rabies Monoclonal Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Monoclonal Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Category II Exposure
Category III Exposure
Segment by Application
Adult
Children
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Serum Institute of India
NCPC
Crucell
Zydus
Synermore Biologics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rabies Monoclonal Antibody Market Size Growth Rate by Type (2021-2027)
1.2.2 Category II Exposure
1.2.3 Category III Exposure
1.3 Market by Application
1.3.1 Global Rabies Monoclonal Antibody Market Share by Application (2021-2027)
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rabies Monoclonal Antibody Market Size
2.2 Rabies Monoclonal Antibody Market Size by Regions
2.2.1 Rabies Monoclonal Antibody Growth Rate by Regions (2021-2027)
2.2.2 Rabies Monoclonal Antibody Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Rabies Monoclonal Antibody Revenue by Players (2020-2021)
3.2 Rabies Monoclonal Antibody Key Players Headquaters and Area Served
3.3 Key Players Rabies Monoclonal Antibody Product/Solution/Service
3.4 Date of Enter into Rabies Monoclonal Antibody Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Rabies Monoclonal Antibody Market Size by Type (2021-2027)
4.2 Global Rabies Monoclonal Antibody Market Size by Application (2021-2027)
5 North America
5.1 North America Rabies Monoclonal Antibody Market Forecast (2021-2027)
5.2 Rabies Monoclonal Antibody Key Players in North America
5.3 North America Rabies Monoclonal Antibody Market Size by Type
5.4 North America Rabies Monoclonal Antibody Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Rabies Monoclonal Antibody Market Forecast (2021-2027)
6.2 Rabies Monoclonal Antibody Key Players in Europe
6.3 Europe Rabies Monoclonal Antibody Market Size by Type
6.4 Europe Rabies Monoclonal Antibody Market Size by Application
7 Japan
7.1 Japan Rabies Monoclonal Antibody Market Forecast (2021-2027)
7.2 Rabies Monoclonal Antibody Key Players in Europe
7.3 Japan Rabies Monoclonal Antibody Market Size by Type
7.4 Japan Rabies Monoclonal Antibody Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Rabies Monoclonal Antibody Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Rabies Monoclonal Antibody Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Rabies Monoclonal Antibody Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Serum Institute of India
9.1.1 Serum Institute of India Company Details
9.1.2 Serum Institute of India Description and Business Overview
9.1.3 Serum Institute of India Rabies Monoclonal Antibody Introduction
9.1.4 Serum Institute of India Revenue in Rabies Monoclonal Antibody Business (2020-2021)
9.1.5 Serum Institute of India Recent Development
9.2 NCPC
9.2.1 NCPC Company Details
9.2.2 NCPC Description and Business Overview
9.2.3 NCPC Rabies Monoclonal Antibody Introduction
9.2.4 NCPC Revenue in Rabies Monoclonal Antibody Business (2020-2021)
9.2.5 NCPC Recent Development
9.3 Crucell
9.3.1 Crucell Company Details
9.3.2 Crucell Description and Business Overview
9.3.3 Crucell Rabies Monoclonal Antibody Introduction
9.3.4 Crucell Revenue in Rabies Monoclonal Antibody Business (2020-2021)
9.3.5 Crucell Recent Development
9.4 Zydus
9.4.1 Zydus Company Details
9.4.2 Zydus Description and Business Overview
9.4.3 Zydus Rabies Monoclonal Antibody Introduction
9.4.4 Zydus Revenue in Rabies Monoclonal Antibody Business (2020-2021)
9.4.5 Zydus Recent Development
9.5 Synermore Biologics
9.5.1 Synermore Biologics Company Details
9.5.2 Synermore Biologics Description and Business Overview
9.5.3 Synermore Biologics Rabies Monoclonal Antibody Introduction
9.5.4 Synermore Biologics Revenue in Rabies Monoclonal Antibody Business (2020-2021)
9.5.5 Synermore Biologics Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Rabies Monoclonal Antibody Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Category II Exposure
Table 3. Key Players of Category III Exposure
Table 4. Global Rabies Monoclonal Antibody Market Size Growth by Application (2021-2027) (US$ Million)
Table 5. Global Rabies Monoclonal Antibody Market Size by Regions (2021-2027) (US$ Million)
Table 6. Global Rabies Monoclonal Antibody Market Share by Regions (2021-2027)
Table 7. Market Top Trends
Table 8. Market Use Cases
Table 9. Global Rabies Monoclonal Antibody Revenue by Players (2020-2021) (US$ Million)
Table 10. Global Rabies Monoclonal Antibody Market Share by Players (2020-2021)
Table 11. Key Players Headquarters and Area Served
Table 12. Key Players Rabies Monoclonal Antibody Product Solution and Service
Table 13. Date of Enter into Rabies Monoclonal Antibody Market
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Global Rabies Monoclonal Antibody Market Size by Type (2021-2027) (US$ Million)
Table 16. Global Rabies Monoclonal Antibody Market Size Share by Type (2021-2027)
Table 17. Global Rabies Monoclonal Antibody Market Size by Application (2021-2027) (US$ Million)
Table 18. Global Rabies Monoclonal Antibody Market Size Share by Application (2021-2027)
Table 19. North America Key Players Rabies Monoclonal Antibody Revenue (2020-2021) (US$ Million)
Table 20. North America Key Players Rabies Monoclonal Antibody Market Share (2020-2021)
Table 21. North America Rabies Monoclonal Antibody Market Size by Type (2021-2027) (US$ Million)
Table 22. North America Rabies Monoclonal Antibody Market Share by Type (2021-2027)
Table 23. North America Rabies Monoclonal Antibody Market Size by Application (2021-2027) (US$ Million)
Table 24. North America Rabies Monoclonal Antibody Market Share by Application (2021-2027)
Table 25. Europe Key Players Rabies Monoclonal Antibody Revenue (2020-2021) (US$ Million)
Table 26. Europe Key Players Rabies Monoclonal Antibody Market Share (2020-2021)
Table 27. Europe Rabies Monoclonal Antibody Market Size by Type (2021-2027) (US$ Million)
Table 28. Europe Rabies Monoclonal Antibody Market Share by Type (2021-2027)
Table 29. Europe Rabies Monoclonal Antibody Market Size by Application (2021-2027) (US$ Million)
Table 30. Europe Rabies Monoclonal Antibody Market Share by Application (2021-2027)
Table 31. Japan Key Players Rabies Monoclonal Antibody Revenue (2020-2021) (US$ Million)
Table 32. Japan Key Players Rabies Monoclonal Antibody Market Share (2020-2021)
Table 33. Japan Rabies Monoclonal Antibody Market Size by Type (2021-2027) (US$ Million)
Table 34. Japan Rabies Monoclonal Antibody Market Share by Type (2021-2027)
Table 35. Japan Rabies Monoclonal Antibody Market Size by Application (2021-2027) (US$ Million)
Table 36. Japan Rabies Monoclonal Antibody Market Share by Application (2021-2027)
Table 37. Key Players in China
Table 38. Key Players in Southeast Asia
Table 39. Key Players in India
Table 40. Serum Institute of India Company Details
Table 41. Serum Institute of India Description and Business Overview
Table 42. Serum Institute of India Rabies Monoclonal Antibody Product
Table 43. Serum Institute of India Revenue in Rabies Monoclonal Antibody Business 2020 and 2021
Table 44. Serum Institute of India Recent Development
Table 45. NCPC Company Details
Table 46. NCPC Description and Business Overview
Table 47. NCPC Rabies Monoclonal Antibody Product
Table 48. NCPC Revenue in Rabies Monoclonal Antibody Business 2020 and 2021
Table 49. NCPC Recent Development
Table 50. Crucell Company Details
Table 51. Crucell Description and Business Overview
Table 52. Crucell Rabies Monoclonal Antibody Product
Table 53. Crucell Revenue in Rabies Monoclonal Antibody Business 2020 and 2021
Table 54. Crucell Recent Development
Table 55. Zydus Company Details
Table 56. Zydus Description and Business Overview
Table 57. Zydus Rabies Monoclonal Antibody Product
Table 58. Zydus Revenue in Rabies Monoclonal Antibody Business 2020 and 2021
Table 59. Zydus Recent Development
Table 60. Synermore Biologics Company Details
Table 61. Synermore Biologics Description and Business Overview
Table 62. Synermore Biologics Rabies Monoclonal Antibody Product
Table 63. Synermore Biologics Revenue in Rabies Monoclonal Antibody Business 2020 and 2021
Table 64. Synermore Biologics Recent Development
Table 65. Rabies Monoclonal Antibody Market Trends
Table 66. Rabies Monoclonal Antibody Market Drivers
Table 67. Rabies Monoclonal Antibody Market Challenges
Table 68. Rabies Monoclonal Antibody Market Restraints
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rabies Monoclonal Antibody Market Share by Type in 2021 & 2027
Figure 2. Category II Exposure Features
Figure 3. Category III Exposure Features
Figure 4. Global Rabies Monoclonal Antibody Market Share by Application in 2021 & 2027
Figure 5. Adult Case Studies
Figure 6. Children Case Studies
Figure 7. Rabies Monoclonal Antibody Report Years Considered
Figure 8. Global Rabies Monoclonal Antibody Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 9. Global Rabies Monoclonal Antibody Market Share by Regions (2020-2027)
Figure 10. Global Rabies Monoclonal Antibody Market Share by Players in 2021
Figure 11. Global Rabies Monoclonal Antibody Market Size Market Share by Type (2021-2027)
Figure 12. Global Rabies Monoclonal Antibody Market Size Market Share by Application (2021-2027)
Figure 13. Global Rabies Monoclonal Antibody Revenue Market Share by Application in 2021
Figure 14. North America Rabies Monoclonal Antibody Market Size 2021-2027 (US$ Million)
Figure 15. Europe Rabies Monoclonal Antibody Market Size 2021-2027 (US$ Million)
Figure 16. Japan Rabies Monoclonal Antibody Market Size 2021-2027 (US$ Million)
Figure 17. Rabies Monoclonal Antibody Market Size in China (2021-2027) (US$ Million)
Figure 18. Rabies Monoclonal Antibody Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 19. Rabies Monoclonal Antibody Market Size in India (2021-2027) (US$ Million)
Figure 20. Bottom-up and Top-down Approaches for This Report
Figure 21. Data Triangulation
Figure 22. Key Executives Interviewed
モノクローナル抗体診断試薬のグローバル市場2021 Monoclonal Antibody Diagnostic Reagents are reagents whose active ingredients are monoclonal antibodies to identify infectious agents, abnormal cells or elements of the body's response to disease. At present, in the foreign industrial developed countries the Monoclonal Antibody Diagnostic Reagents i…- 世界のがんモノクローナル抗体提携条件＆契約市場規模・現状・予測（2021年-2027年） Monoclonal antibodies are single cell clones of antibodies, a biochemical tool that allows scientists to create antibodies that combine the specificity of specific substances. There are many reasons for the medical community to support the use of monoclonal antibodies in cancer treatment. There are …
- 世界の狂犬病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rabies Treatment Market The global Rabies Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界のヒト狂犬病治療市場規模・現状・予測（2021年-2027年） Rabies is a fatal neurological disease, usually spread to humans through the bite of a rabid animal, and it is a persistent global problem. Market Analysis and Insights: Global Human Rabies Treatment Market The global Human Rabies Treatment market size is projected to reach US$ XX million by 2027, f…
- 狂犬病ワクチンのグローバル市場2021 Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With…